These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17253568)

  • 1. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia.
    Osborn DA; Hunt RW
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005945. PubMed ID: 17253568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants.
    Osborn DA; Hunt RW
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005948. PubMed ID: 17253571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants.
    Osborn DA; Hunt RW
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005946. PubMed ID: 17253569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone for preventing of neurodevelopmental impairment in preterm infants.
    Osborn DA
    Cochrane Database Syst Rev; 2000; 2001(2):CD001070. PubMed ID: 10796406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants.
    Osborn DA
    Cochrane Database Syst Rev; 2001; (4):CD001070. PubMed ID: 11687092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Ibrahim M; Sinn J; McGuire W
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005253. PubMed ID: 16625632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow.
    Osborn DA; Paradisis M; Evans N
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005090. PubMed ID: 17253539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.
    Cooke L; Steer P; Woodgate P
    Cochrane Database Syst Rev; 2003; 2003(2):CD003745. PubMed ID: 12804488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher S; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral iron supplementation in preterm and low birth weight infants.
    Mills RJ; Davies MW
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD005095. PubMed ID: 22419305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Walsh V; Brown JVE; McGuire W
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD005253. PubMed ID: 30802939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia.
    Williams F; Hume R
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):7-22. PubMed ID: 20930033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant.
    van Wassenaer AG; Stulp MR; Valianpour F; Tamminga P; Ris Stalpers C; de Randamie JS; van Beusekom C; de Vijlder JJ
    Clin Endocrinol (Oxf); 2002 May; 56(5):621-7. PubMed ID: 12030913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early introduction of lipids to parenterally-fed preterm infants.
    Simmer K; Rao SC
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005256. PubMed ID: 15846747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.